• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form NT 10-Q filed by PACS Group Inc.

    11/17/25 9:00:16 AM ET
    $PACS
    Hospital/Nursing Management
    Health Care
    Get the next $PACS alert in real time by email
    NT 10-Q 1 pacsgroupinc12b-25xq320251.htm NT 10-Q Document

     
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    FORM 12b-25
     
    NOTIFICATION OF LATE FILING
     
    SEC File Number: 001-42011
    CUSIP Number: 69380Q107
     
    (Check one):
     
    ☐ Form 10-K
    ☐ Form 20-F
    ☐ Form 11-K
    ☒  Form 10-Q
    ☐ Form 10-D
     
     
    ☐ Form N-SAR
    ☐ Form N-CSR
     
     
     
     
     
     
     
     
     
     
     
     
    For Period Ended:September 30, 2025
     
     
    ☐ Transition Report on Form 10-K
     
     
     
     
    ☐ Transition Report on Form 20-F
     
     
     
     
    ☐ Transition Report on Form 11-K
     
     
     
     
    ☐ Transition Report on Form 10-Q
     
     
     
     
    ☐ Transition Report on Form N-SAR
     
     
     
     
    For the Transition Period Ended:
     
    Nothing in this Form shall be construed to imply that the Commission has verified any information contained herein.
     
    If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates: Not Applicable



    PART I — REGISTRANT INFORMATION
     
    PACS GROUP, INC.
    Full Name of Registrant
     
    N/A
    Former Name if Applicable
     
    262 N. University Avenue
    Address of Principal Executive Office (Street and Number)
     
    Farmington, UT 84025
    City, State and Zip Code
     
    PART II — RULES 12b-25(b) AND (c)
     
    If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

    ☒(a)
    The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense
    (b)
    The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
    (c)
    The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.
     
    PART III — NARRATIVE
    State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.
    PACS Group, Inc. (the “Company”) has determined that it is unable to file its Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2025 (the “Q3 2025 10-Q”) within the prescribed time period without unreasonable effort or expense due to the previously disclosed Audit Committee investigation and restatement of its condensed combined/consolidated financial statements for the quarterly periods ended March 31, 2024 and June 30, 2024 (the “Impacted Periods”). The Company expects to file its Q3 2025 10-Q with the Securities and Exchange Commission by November 19, 2025, concurrent with the restatement of the Company's condensed combined/consolidated financial statements for the Impacted Periods and the filing of its Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2024, Annual Report on Form 10-K for the year ended December 31, 2024, and Quarterly Reports on Form 10-Q for the quarterly periods ended March 31, 2025 and June 30, 2025 (such reports, together with the Q3 2025 10-Q, the “Periodic Reports”).
    Forward-Looking Statements
    This Notification of Late Filing on Form 12b-25 contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Words such as “expect,” “will,” “anticipates,” “estimates” and variations of such words and similar future



    or conditional expressions are intended to identify forward-looking statements. These forward-looking statements include, but are not limited to, statements regarding the Company’s expectation of filing the Periodic Reports with the SEC by November 19, 2025. Forward-looking statements are based on management’s current expectations based on information currently available to the Company. Forward-looking statements are subject to known and unknown risks, uncertainties and assumptions, and actual results or outcomes may differ materially from those expressed or implied in the forward-looking statements due to various important factors, including, but not limited to the restatement process and return to current reporting may not be completed on the anticipated timeline; risks relating to the ongoing Audit Committee investigation; the risk of a delisting determination by the New York Stock Exchange; and the other risks described in the Company’s filings with the Securities and Exchange Commission. All forward-looking statements speak only as of the date of this Notification of Late Filing on Form 12b-25 and, except as required by applicable law, the Company has no obligation to update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise.
    PART IV — OTHER INFORMATION
    (1)Name and telephone number of person to contact in regard to this notification
     
    Jason Murray
     
    801
     
    447-9829
     
    (Name)
     
    (Area Code)
     
    (Telephone Number)
     
     
    (2)
    Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s).
    The Company's Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2024, the Company's Annual Report on Form 10-K for the year ended December 31, 2024, and the Company's Quarterly Reports on Form 10-Q for the quarterly periods ended March 30, 2025 and June 30, 2025, have not been filed.
     
     
     
     
     
     
     
    ☐ Yes     ☒ No
     
    (3)Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?
     
     
     
     
     
     
     
    ☐ Yes    ☒ No
     
     
    If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

     




    PACS GROUP, INC.
    (Name of Registrant as Specified in Charter)

    has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.
     
    DateNovember 17, 2025
     
    By/s/ Jason Murray
     
     
     
    Name: Jason Murray
    Title: Chief Executive Officer



    Get the next $PACS alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $PACS

    DatePrice TargetRatingAnalyst
    12/17/2024$18.00Overweight → Neutral
    Analyst
    11/6/2024$40.00Overweight
    JP Morgan
    10/9/2024$50.00Buy
    UBS
    9/11/2024$45.00Buy
    Citigroup
    6/28/2024$35.00Outperform
    Macquarie
    More analyst ratings

    $PACS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    PACS Group downgraded by Analyst with a new price target

    Analyst downgraded PACS Group from Overweight to Neutral and set a new price target of $18.00

    12/17/24 8:16:05 AM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    JP Morgan resumed coverage on PACS Group with a new price target

    JP Morgan resumed coverage of PACS Group with a rating of Overweight and set a new price target of $40.00

    11/6/24 6:27:46 AM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    UBS initiated coverage on PACS Group with a new price target

    UBS initiated coverage of PACS Group with a rating of Buy and set a new price target of $50.00

    10/9/24 7:56:46 AM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    $PACS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    $PACS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    $PACS
    SEC Filings

    View All

    PACS Group, Inc. Reports Third Quarter 2025 Results

    Completes Restatement of Previously Issued Financial Statements and Now Current with SEC Filing Obligations Audit Committee Completes Investigation Conference Call and Webcast Scheduled for Today, November 19, 2025, at 5:30 pm ET. PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company"), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United States, announced operating results for the third quarter of 2025. The Company has completed the previously announced Restatement of its financial statements for the three months ended March 31, 2024, and for the three and six months ended on June 30, 2024 (the "Restatement"), and is current with its

    11/19/25 4:30:00 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    PACS Group Intends to Release Third Quarter 2025 Earnings and Submit SEC Filings on November 19, 2025

    PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company"), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United States, today announced that it intends to release its third quarter 2025 financial results and file its outstanding annual and quarterly filings through September 30, 2025 with the U.S. Securities and Exchange Commission (the "SEC") on Wednesday, November 19, 2025. Management will host a call on Wednesday, November 19, 2025, at 5:30 p.m. ET to discuss the financial results and related information. The Company today filed a Form 12b-25, Notification of Late Filing, with the SEC related to its Quarterly Report on Form 10-Q for th

    11/17/25 9:05:00 AM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    PACS Group Announces NYSE Listing Extension and Provides Select Preliminary Interim Operating Metrics

    PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company"), on September 10, 2025, announced that on September 9, 2025, the New York Stock Exchange ("NYSE") Listing Operations Committee agreed to provide the Company with an additional trading period through November 19, 2025, subject to its ongoing review of the Company. The additional trading period provides PACS additional time to complete the previously announced restatement of its financial statements for the three months ended March 31, 2024, and the three and six months ended June 30, 2024 and become current with its SEC filing obligations, which are required for the Company to regain compliance with the NYSE listing standards. "We have

    9/11/25 8:17:00 AM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    Chief Accounting Officer Lewis Michelle Renee covered exercise/tax liability with 16,777 shares, decreasing direct ownership by 5% to 326,591 units (SEC Form 4)

    4 - PACS Group, Inc. (0002001184) (Issuer)

    4/16/25 7:32:30 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    Chief Compliance Officer Lee Joseph Robert covered exercise/tax liability with 28,763 shares, decreasing direct ownership by 4% to 648,122 units (SEC Form 4)

    4 - PACS Group, Inc. (0002001184) (Issuer)

    4/16/25 7:31:48 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    Officer Sanford Peter covered exercise/tax liability with 72,924 shares, decreasing direct ownership by 5% to 1,280,872 units (SEC Form 4)

    4 - PACS Group, Inc. (0002001184) (Issuer)

    4/16/25 7:31:05 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    SEC Form S-8 filed by PACS Group Inc.

    S-8 - PACS Group, Inc. (0002001184) (Filer)

    11/19/25 4:07:14 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    PACS Group Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - PACS Group, Inc. (0002001184) (Filer)

    11/19/25 4:06:20 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    SEC Form 10-Q filed by PACS Group Inc.

    10-Q - PACS Group, Inc. (0002001184) (Filer)

    11/19/25 4:05:41 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    $PACS
    Financials

    Live finance-specific insights

    View All

    PACS Group, Inc. Reports Third Quarter 2025 Results

    Completes Restatement of Previously Issued Financial Statements and Now Current with SEC Filing Obligations Audit Committee Completes Investigation Conference Call and Webcast Scheduled for Today, November 19, 2025, at 5:30 pm ET. PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company"), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United States, announced operating results for the third quarter of 2025. The Company has completed the previously announced Restatement of its financial statements for the three months ended March 31, 2024, and for the three and six months ended on June 30, 2024 (the "Restatement"), and is current with its

    11/19/25 4:30:00 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    PACS Group Intends to Release Third Quarter 2025 Earnings and Submit SEC Filings on November 19, 2025

    PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company"), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United States, today announced that it intends to release its third quarter 2025 financial results and file its outstanding annual and quarterly filings through September 30, 2025 with the U.S. Securities and Exchange Commission (the "SEC") on Wednesday, November 19, 2025. Management will host a call on Wednesday, November 19, 2025, at 5:30 p.m. ET to discuss the financial results and related information. The Company today filed a Form 12b-25, Notification of Late Filing, with the SEC related to its Quarterly Report on Form 10-Q for th

    11/17/25 9:05:00 AM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    PACS Group Provides Preliminary Third Quarter Operational Metrics

    Postpones Third Quarter 2024 Financial Results Conference Call PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company"), today provided select preliminary key operating metrics for the third quarter and announced the postponement of the release of its third quarter 2024 financial results. PACS expects to release its third quarter 2024 financial results as soon as practicable. "PACS Group operates in a highly regulated industry where compliance is of the utmost importance," said Jason Murray, PACS's Chief Executive Officer. "We believe recent third-party allegations are misleading. However, in line with our commitment to holding ourselves to a high standard – in how we serve our patients, op

    11/6/24 6:00:00 AM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    $PACS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by PACS Group Inc.

    SC 13G - PACS Group, Inc. (0002001184) (Subject)

    11/14/24 5:15:49 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    SEC Form SC 13G filed by PACS Group Inc.

    SC 13G - PACS Group, Inc. (0002001184) (Subject)

    11/14/24 5:15:15 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    SEC Form SC 13G filed by PACS Group Inc.

    SC 13G - PACS Group, Inc. (0002001184) (Subject)

    11/14/24 11:37:42 AM ET
    $PACS
    Hospital/Nursing Management
    Health Care